F Rothweiler

Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells

R. Breitling, A. von Deimling, T. Stiewe, 2011, Cell Death and Disease.

Preparation, characterisation and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticles.

M. Michaelis, J. Cinatl, J. Kreuter, 2007, International journal of pharmaceutics.